BLT 0.00% 2.6¢ benitec biopharma limited

Ann: Appendix 3B, page-19

  1. 863 Posts.
    lightbulb Created with Sketch. 32
    Nuffin for nuffin!
    All staff & management options should be performance based. Furthermore they shouldn't be based on Mick Graham's work alone. We know that's a winner anyway. Perfect conduct of clinicals, proof of Mick's concepts, targeting of profitable disease needs etc by RNAi technical staff are what is important. Bean counters & lawyers are a dime a dozen.
    However, you watch who comes out of the mixing pot with all the jam. Cheers, Japes
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.